What does Nunzia Pharmaceutical Company do?

Nunzia Pharmaceutical Company (NUNZ) operates in the Medical - Pharmaceuticals industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is NUNZ's market cap?

Nunzia Pharmaceutical Company (NUNZ) has a market capitalization of approximately $43,451, as of August 25, 2026, based on the most recent share price and shares outstanding.

Does NUNZ pay a dividend?

No — Nunzia Pharmaceutical Company (NUNZ) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

Nunzia Pharmaceutical Company (NUNZ) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

NUNZ

Nunzia Pharmaceutical Company

OTC·Medical, Pharmaceuticals · Healthcare

$0.00$0.00+0.00%

Market cap$43.45K·Aug 25 8:00 PM UTC

Price Chart

$0.00+$0.00 (+0.00%)today

−100.00%CAGR −87.30%

Select date range

FromTo

Jul 24, 2009Aug 26, 2021 → Aug 26, 2026· 5.0 yrsAug 26, 2026

Key Metrics

NUNZ does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings Date—

Last Report Date—

Reported vs Estimate—

Earnings Surprise—

FinancialsFinancials Tab

Revenue$0.00

Net Income−$96.99M

Net Margin—

Operating Cash Flow−$277.92K

Capital Expenditures$0.00

Free Cash Flow−$277.92K

Return on Equity—

Return on Invested Capital7,642.1%

Net Debt$147.97K

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for NUNZ and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how NUNZ's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for NUNZ and 80,000+ other tickers.

About Nunzia Pharmaceutical Company

Nunzia Pharmaceutical Company operates as a pharmaceutical and nutraceutical company. The company owns the right to manufacture, market, and distribute Nunzia, a nutraceutical that treats autism, fragile X, ADHD, PTSD, and other disorders. It offers its products through wholesalers, as well as through its website nunziapharma.com. The company was formerly known as Arizona Gold and Onyx Mining Company and changed its name to Nunzia Pharmaceutical Company in February 2018. Nunzia Pharmaceutical Company was incorporated in 1986 and is based in Long Beach, California.

CEO: Sara Gonzales
Sector: Healthcare
Industry: Medical - Pharmaceuticals
Exchange: OTC
Employees: 4
Website: www.nunziapharma.com

Peers

Cannabis Suisse Corp.

Latest News

News Tab

No recent news available.

Frequently Asked Questions About NUNZ

What does Nunzia Pharmaceutical Company do?: Nunzia Pharmaceutical Company (NUNZ) operates in the Medical - Pharmaceuticals industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is NUNZ's market cap?: Nunzia Pharmaceutical Company (NUNZ) has a market capitalization of approximately $43,451, as of August 25, 2026, based on the most recent share price and shares outstanding.
Does NUNZ pay a dividend?: No — Nunzia Pharmaceutical Company (NUNZ) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.
Is NUNZ profitable?: Nunzia Pharmaceutical Company (NUNZ) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.